These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 23439585)

  • 1. Altered folate receptor 2 expression in uraemic patients on haemodialysis: implications for folate resistance.
    Perna AF; Lanza D; Sepe I; Conzo G; Altucci L; Ingrosso D
    Nephrol Dial Transplant; 2013 May; 28(5):1214-24. PubMed ID: 23439585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence Favoring a Positive Feedback Loop for Physiologic Auto Upregulation of hnRNP-E1 during Prolonged Folate Deficiency in Human Placental Cells.
    Tang YS; Khan RA; Xiao S; Hansen DK; Stabler SP; Kusumanchi P; Jayaram HN; Antony AC
    J Nutr; 2017 Apr; 147(4):482-498. PubMed ID: 28250194
    [No Abstract]   [Full Text] [Related]  

  • 3. Maternal folate deficiency results in selective upregulation of folate receptors and heterogeneous nuclear ribonucleoprotein-E1 associated with multiple subtle aberrations in fetal tissues.
    Xiao S; Hansen DK; Horsley ET; Tang YS; Khan RA; Stabler SP; Jayaram HN; Antony AC
    Birth Defects Res A Clin Mol Teratol; 2005 Jan; 73(1):6-28. PubMed ID: 15641086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incrimination of heterogeneous nuclear ribonucleoprotein E1 (hnRNP-E1) as a candidate sensor of physiological folate deficiency.
    Tang YS; Khan RA; Zhang Y; Xiao S; Wang M; Hansen DK; Jayaram HN; Antony A
    J Biol Chem; 2011 Nov; 286(45):39100-15. PubMed ID: 21930702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational upregulation of folate receptors is mediated by homocysteine via RNA-heterogeneous nuclear ribonucleoprotein E1 interactions.
    Antony A; Tang YS; Khan RA; Biju MP; Xiao X; Li QJ; Sun XL; Jayaram HN; Stabler SP
    J Clin Invest; 2004 Jan; 113(2):285-301. PubMed ID: 14722620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients.
    Righetti M; Serbelloni P; Milani S; Ferrario G
    Blood Purif; 2006; 24(4):379-86. PubMed ID: 16755160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
    Nakamura T; Saionji K; Hiejima Y; Hirayama H; Tago K; Takano H; Tajiri M; Hayashi K; Kawabata M; Funamizu M; Makita Y; Hata A
    Am J Kidney Dis; 2002 May; 39(5):1032-9. PubMed ID: 11979347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation.
    Stopper H; Treutlein AT; Bahner U; Schupp N; Schmid U; Brink A; Perna A; Heidland A
    Nephrol Dial Transplant; 2008 Oct; 23(10):3272-9. PubMed ID: 18469307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
    Alhamdani MS
    Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of haemodialysis and left ventricular failure on peripheral A(2A) adenosine receptor expression.
    Carrega L; Fenouillet E; Giaime P; Charavil A; Mercier L; Gerolami V; Berge-Lefranc JL; Berland Y; Ruf J; Saadjian A; Dussol B; Guieu R
    Nephrol Dial Transplant; 2007 Mar; 22(3):851-6. PubMed ID: 17132707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of folate transporters in human placenta and implications for homocysteine metabolism.
    Solanky N; Requena Jimenez A; D'Souza SW; Sibley CP; Glazier JD
    Placenta; 2010 Feb; 31(2):134-43. PubMed ID: 20036773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
    Sjöberg B; Anderstam B; Suliman M; Alvestrand A
    Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid reduces chemokine MCP-1 release and expression in rats with hyperhomocystinemia.
    Li M; Chen J; Li YS; Feng YB; Zeng QT
    Cardiovasc Pathol; 2007; 16(5):305-9. PubMed ID: 17868882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients.
    Kimmel M; Alscher DM; Dunst R; Braun N; Machleidt C; Kiefer T; Stülten C; van der Kuip H; Pauli-Magnus C; Raub U; Kuhlmann U; Mettang T
    Nephrol Dial Transplant; 2006 Mar; 21(3):749-55. PubMed ID: 16249205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice.
    Santana AC; Degaspari S; Catanozi S; Dellê H; de Sá Lima L; Silva C; Blanco P; Solez K; Scavone C; Noronha IL
    Nephrol Dial Transplant; 2013 May; 28(5):1140-9. PubMed ID: 23345625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid reduces adhesion molecules VCAM-1 expession in aortic of rats with hyperhomocysteinemia.
    Li M; Chen J; Li YS; Feng YB; Gu X; Shi CZ
    Int J Cardiol; 2006 Jan; 106(2):285-8. PubMed ID: 16183151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uraemia disrupts the vascular niche in a 3D co-culture system of human mesenchymal stem cells and endothelial cells.
    Kramann R; Couson SK; Neuss S; Floege J; Knüchel R; Schneider RK
    Nephrol Dial Transplant; 2012 Jul; 27(7):2693-702. PubMed ID: 22207324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinemia in children on renal replacement therapy.
    Feinstein S; Sela BA; Drukker A; Becker-Cohen R; Raveh D; Gavendo S; Frishberg Y
    Pediatr Nephrol; 2002 Jul; 17(7):515-9. PubMed ID: 12172765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of reduced-folate transporter-1 (RFT-1) by homocysteine and identity of transport systems for homocysteine uptake in retinal pigment epithelial (RPE) cells.
    Naggar H; Fei YJ; Ganapathy V; Smith SB
    Exp Eye Res; 2003 Dec; 77(6):687-97. PubMed ID: 14609557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hyperhomocysteinaemia in haemodialysis patients at high cardiovascular risk.
    Manca di Villahermosa S; Tedesco M; Lonzi M; Della Rovere FR; De Francesco M; Noce A; Colarieti G; Chamoun G; Moscaritolo E; Bernabei E; Athanasopoulou E; Di Giandomenico G; Taccone-Gallucci M
    Clin Ter; 2009; 160(1):11-5. PubMed ID: 19290406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.